Human Papilloma Virus Testing Market, Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: HD25CA4D3FDCEN
Market Monitor Global

Abstracts

HPV testing and Pap test market has been divided into two major segments on basis of test type, namely, HPV testing and Pap test.

This report contains market size and forecasts of Human Papilloma Virus Testing in Global, including the following market information:

Global Human Papilloma Virus Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Human Papilloma Virus Testing market was valued at 778.9 million in 2021 and is projected to reach US$ 1110.5 million by 2028, at a CAGR of 5.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Systems Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Human Papilloma Virus Testing include Abbott Laboratories, Qiagen NV, Becton, Dickinson and Company, Quest Diagnostics, Hologic Inc., Roche, Arbor Vita Corporation and Femasys Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Papilloma Virus Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Human Papilloma Virus Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Human Papilloma Virus Testing Market Segment Percentages, by Type, 2021 (%)

• Systems
• Assay Kits
• Services

Global Human Papilloma Virus Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Human Papilloma Virus Testing Market Segment Percentages, by Application, 2021 (%)

• Cervical Cancer Screening
• Vaginal Cancer Screening

Global Human Papilloma Virus Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Human Papilloma Virus Testing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Human Papilloma Virus Testing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Human Papilloma Virus Testing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• Qiagen NV
• Becton
• Dickinson and Company
• Quest Diagnostics
• Hologic Inc.
• Roche
• Arbor Vita Corporation
• Femasys Inc.
• Onco Health Corporation
• Seegene Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Human Papilloma Virus Testing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Human Papilloma Virus Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HUMAN PAPILLOMA VIRUS TESTING OVERALL MARKET SIZE

2.1 Global Human Papilloma Virus Testing Market Size: 2021 VS 2028
2.2 Global Human Papilloma Virus Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Human Papilloma Virus Testing Players in Global Market
3.2 Top Global Human Papilloma Virus Testing Companies Ranked by Revenue
3.3 Global Human Papilloma Virus Testing Revenue by Companies
3.4 Top 3 and Top 5 Human Papilloma Virus Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Human Papilloma Virus Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Papilloma Virus Testing Players in Global Market
  3.6.1 List of Global Tier 1 Human Papilloma Virus Testing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Human Papilloma Virus Testing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Human Papilloma Virus Testing Market Size Markets, 2021 & 2028
  4.1.2 Systems
  4.1.3 Assay Kits
  4.1.4 Services
4.2 By Type - Global Human Papilloma Virus Testing Revenue & Forecasts
  4.2.1 By Type - Global Human Papilloma Virus Testing Revenue, 2017-2022
  4.2.2 By Type - Global Human Papilloma Virus Testing Revenue, 2023-2028
  4.2.3 By Type - Global Human Papilloma Virus Testing Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Human Papilloma Virus Testing Market Size, 2021 & 2028
  5.1.2 Cervical Cancer Screening
  5.1.3 Vaginal Cancer Screening
5.2 By Application - Global Human Papilloma Virus Testing Revenue & Forecasts
  5.2.1 By Application - Global Human Papilloma Virus Testing Revenue, 2017-2022
  5.2.2 By Application - Global Human Papilloma Virus Testing Revenue, 2023-2028
  5.2.3 By Application - Global Human Papilloma Virus Testing Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Human Papilloma Virus Testing Market Size, 2021 & 2028
6.2 By Region - Global Human Papilloma Virus Testing Revenue & Forecasts
  6.2.1 By Region - Global Human Papilloma Virus Testing Revenue, 2017-2022
  6.2.2 By Region - Global Human Papilloma Virus Testing Revenue, 2023-2028
  6.2.3 By Region - Global Human Papilloma Virus Testing Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Human Papilloma Virus Testing Revenue, 2017-2028
  6.3.2 US Human Papilloma Virus Testing Market Size, 2017-2028
  6.3.3 Canada Human Papilloma Virus Testing Market Size, 2017-2028
  6.3.4 Mexico Human Papilloma Virus Testing Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Human Papilloma Virus Testing Revenue, 2017-2028
  6.4.2 Germany Human Papilloma Virus Testing Market Size, 2017-2028
  6.4.3 France Human Papilloma Virus Testing Market Size, 2017-2028
  6.4.4 U.K. Human Papilloma Virus Testing Market Size, 2017-2028
  6.4.5 Italy Human Papilloma Virus Testing Market Size, 2017-2028
  6.4.6 Russia Human Papilloma Virus Testing Market Size, 2017-2028
  6.4.7 Nordic Countries Human Papilloma Virus Testing Market Size, 2017-2028
  6.4.8 Benelux Human Papilloma Virus Testing Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Human Papilloma Virus Testing Revenue, 2017-2028
  6.5.2 China Human Papilloma Virus Testing Market Size, 2017-2028
  6.5.3 Japan Human Papilloma Virus Testing Market Size, 2017-2028
  6.5.4 South Korea Human Papilloma Virus Testing Market Size, 2017-2028
  6.5.5 Southeast Asia Human Papilloma Virus Testing Market Size, 2017-2028
  6.5.6 India Human Papilloma Virus Testing Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Human Papilloma Virus Testing Revenue, 2017-2028
  6.6.2 Brazil Human Papilloma Virus Testing Market Size, 2017-2028
  6.6.3 Argentina Human Papilloma Virus Testing Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Human Papilloma Virus Testing Revenue, 2017-2028
  6.7.2 Turkey Human Papilloma Virus Testing Market Size, 2017-2028
  6.7.3 Israel Human Papilloma Virus Testing Market Size, 2017-2028
  6.7.4 Saudi Arabia Human Papilloma Virus Testing Market Size, 2017-2028
  6.7.5 UAE Human Papilloma Virus Testing Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Human Papilloma Virus Testing Major Product Offerings
  7.1.4 Abbott Laboratories Human Papilloma Virus Testing Revenue in Global Market (2017-2022)
  7.1.5 Abbott Laboratories Key News
7.2 Qiagen NV
  7.2.1 Qiagen NV Corporate Summary
  7.2.2 Qiagen NV Business Overview
  7.2.3 Qiagen NV Human Papilloma Virus Testing Major Product Offerings
  7.2.4 Qiagen NV Human Papilloma Virus Testing Revenue in Global Market (2017-2022)
  7.2.5 Qiagen NV Key News
7.3 Becton
  7.3.1 Becton Corporate Summary
  7.3.2 Becton Business Overview
  7.3.3 Becton Human Papilloma Virus Testing Major Product Offerings
  7.3.4 Becton Human Papilloma Virus Testing Revenue in Global Market (2017-2022)
  7.3.5 Becton Key News
7.4 Dickinson and Company
  7.4.1 Dickinson and Company Corporate Summary
  7.4.2 Dickinson and Company Business Overview
  7.4.3 Dickinson and Company Human Papilloma Virus Testing Major Product Offerings
  7.4.4 Dickinson and Company Human Papilloma Virus Testing Revenue in Global Market (2017-2022)
  7.4.5 Dickinson and Company Key News
7.5 Quest Diagnostics
  7.5.1 Quest Diagnostics Corporate Summary
  7.5.2 Quest Diagnostics Business Overview
  7.5.3 Quest Diagnostics Human Papilloma Virus Testing Major Product Offerings
  7.5.4 Quest Diagnostics Human Papilloma Virus Testing Revenue in Global Market (2017-2022)
  7.5.5 Quest Diagnostics Key News
7.6 Hologic Inc.
  7.6.1 Hologic Inc. Corporate Summary
  7.6.2 Hologic Inc. Business Overview
  7.6.3 Hologic Inc. Human Papilloma Virus Testing Major Product Offerings
  7.6.4 Hologic Inc. Human Papilloma Virus Testing Revenue in Global Market (2017-2022)
  7.6.5 Hologic Inc. Key News
7.7 Roche
  7.7.1 Roche Corporate Summary
  7.7.2 Roche Business Overview
  7.7.3 Roche Human Papilloma Virus Testing Major Product Offerings
  7.7.4 Roche Human Papilloma Virus Testing Revenue in Global Market (2017-2022)
  7.7.5 Roche Key News
7.8 Arbor Vita Corporation
  7.8.1 Arbor Vita Corporation Corporate Summary
  7.8.2 Arbor Vita Corporation Business Overview
  7.8.3 Arbor Vita Corporation Human Papilloma Virus Testing Major Product Offerings
  7.8.4 Arbor Vita Corporation Human Papilloma Virus Testing Revenue in Global Market (2017-2022)
  7.8.5 Arbor Vita Corporation Key News
7.9 Femasys Inc.
  7.9.1 Femasys Inc. Corporate Summary
  7.9.2 Femasys Inc. Business Overview
  7.9.3 Femasys Inc. Human Papilloma Virus Testing Major Product Offerings
  7.9.4 Femasys Inc. Human Papilloma Virus Testing Revenue in Global Market (2017-2022)
  7.9.5 Femasys Inc. Key News
7.10 Onco Health Corporation
  7.10.1 Onco Health Corporation Corporate Summary
  7.10.2 Onco Health Corporation Business Overview
  7.10.3 Onco Health Corporation Human Papilloma Virus Testing Major Product Offerings
  7.10.4 Onco Health Corporation Human Papilloma Virus Testing Revenue in Global Market (2017-2022)
  7.10.5 Onco Health Corporation Key News
7.11 Seegene Inc.
  7.11.1 Seegene Inc. Corporate Summary
  7.11.2 Seegene Inc. Business Overview
  7.11.3 Seegene Inc. Human Papilloma Virus Testing Major Product Offerings
  7.11.4 Seegene Inc. Human Papilloma Virus Testing Revenue in Global Market (2017-2022)
  7.11.5 Seegene Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Human Papilloma Virus Testing Market Opportunities & Trends in Global Market
Table 2. Human Papilloma Virus Testing Market Drivers in Global Market
Table 3. Human Papilloma Virus Testing Market Restraints in Global Market
Table 4. Key Players of Human Papilloma Virus Testing in Global Market
Table 5. Top Human Papilloma Virus Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Human Papilloma Virus Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Human Papilloma Virus Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Human Papilloma Virus Testing Product Type
Table 9. List of Global Tier 1 Human Papilloma Virus Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Papilloma Virus Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Human Papilloma Virus Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Human Papilloma Virus Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Human Papilloma Virus Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Human Papilloma Virus Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Human Papilloma Virus Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Human Papilloma Virus Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Human Papilloma Virus Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Human Papilloma Virus Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Human Papilloma Virus Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Human Papilloma Virus Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Human Papilloma Virus Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Human Papilloma Virus Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Human Papilloma Virus Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Human Papilloma Virus Testing Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Human Papilloma Virus Testing Product Offerings
Table 32. Abbott Laboratories Human Papilloma Virus Testing Revenue (US$, Mn), (2017-2022)
Table 33. Qiagen NV Corporate Summary
Table 34. Qiagen NV Human Papilloma Virus Testing Product Offerings
Table 35. Qiagen NV Human Papilloma Virus Testing Revenue (US$, Mn), (2017-2022)
Table 36. Becton Corporate Summary
Table 37. Becton Human Papilloma Virus Testing Product Offerings
Table 38. Becton Human Papilloma Virus Testing Revenue (US$, Mn), (2017-2022)
Table 39. Dickinson and Company Corporate Summary
Table 40. Dickinson and Company Human Papilloma Virus Testing Product Offerings
Table 41. Dickinson and Company Human Papilloma Virus Testing Revenue (US$, Mn), (2017-2022)
Table 42. Quest Diagnostics Corporate Summary
Table 43. Quest Diagnostics Human Papilloma Virus Testing Product Offerings
Table 44. Quest Diagnostics Human Papilloma Virus Testing Revenue (US$, Mn), (2017-2022)
Table 45. Hologic Inc. Corporate Summary
Table 46. Hologic Inc. Human Papilloma Virus Testing Product Offerings
Table 47. Hologic Inc. Human Papilloma Virus Testing Revenue (US$, Mn), (2017-2022)
Table 48. Roche Corporate Summary
Table 49. Roche Human Papilloma Virus Testing Product Offerings
Table 50. Roche Human Papilloma Virus Testing Revenue (US$, Mn), (2017-2022)
Table 51. Arbor Vita Corporation Corporate Summary
Table 52. Arbor Vita Corporation Human Papilloma Virus Testing Product Offerings
Table 53. Arbor Vita Corporation Human Papilloma Virus Testing Revenue (US$, Mn), (2017-2022)
Table 54. Femasys Inc. Corporate Summary
Table 55. Femasys Inc. Human Papilloma Virus Testing Product Offerings
Table 56. Femasys Inc. Human Papilloma Virus Testing Revenue (US$, Mn), (2017-2022)
Table 57. Onco Health Corporation Corporate Summary
Table 58. Onco Health Corporation Human Papilloma Virus Testing Product Offerings
Table 59. Onco Health Corporation Human Papilloma Virus Testing Revenue (US$, Mn), (2017-2022)
Table 60. Seegene Inc. Corporate Summary
Table 61. Seegene Inc. Human Papilloma Virus Testing Product Offerings
Table 62. Seegene Inc. Human Papilloma Virus Testing Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Human Papilloma Virus Testing Segment by Type in 2021
Figure 2. Human Papilloma Virus Testing Segment by Application in 2021
Figure 3. Global Human Papilloma Virus Testing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Human Papilloma Virus Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Human Papilloma Virus Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Human Papilloma Virus Testing Revenue in 2021
Figure 8. By Type - Global Human Papilloma Virus Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Human Papilloma Virus Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Human Papilloma Virus Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Human Papilloma Virus Testing Revenue Market Share, 2017-2028
Figure 12. US Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Human Papilloma Virus Testing Revenue Market Share, 2017-2028
Figure 16. Germany Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Human Papilloma Virus Testing Revenue Market Share, 2017-2028
Figure 24. China Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Human Papilloma Virus Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Human Papilloma Virus Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Human Papilloma Virus Testing Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Human Papilloma Virus Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Qiagen NV Human Papilloma Virus Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Becton Human Papilloma Virus Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Dickinson and Company Human Papilloma Virus Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Quest Diagnostics Human Papilloma Virus Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Hologic Inc. Human Papilloma Virus Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Roche Human Papilloma Virus Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Arbor Vita Corporation Human Papilloma Virus Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Femasys Inc. Human Papilloma Virus Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Onco Health Corporation Human Papilloma Virus Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Seegene Inc. Human Papilloma Virus Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)